(Q28193753)

4

0 references

Deepak L. Bhatt

1

object named as

Deepak L Bhatt

0 references

author name string

Steven P Marso

2

0 references

Alan T Hirsch

3

0 references

Werner Hacke

American Journal of Cardiology

5

0 references

language of work or name

English

0 references

publication date

15 September 2002

0 references

published in

0 references

volume

90

0 references

issue

6

0 references

page(s)

625-8

0 references

cites work

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Activated platelets in subjects at increased risk of IDDM. DENIS Study Group. Deutsche Nikotinamid Interventionsstudie.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Platelet-leukocyte-cross-talk in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902567-5